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The c-Jun NH2-terminal kinase (JNK) is implicated in proliferation. Mice with a deficiency of either the Jnk1
or the Jnk2 genes are viable, but a compound deficiency of both Jnk1 and Jnk2 causes early embryonic lethality.
Studies using conditional gene ablation and chemical genetic approaches demonstrate that the combined loss
of JNK1 and JNK2 protein kinase function results in rapid senescence. To test whether this role of JNK was
required for stem cell proliferation, we isolated embryonic stem (ES) cells from wild-type and JNK-deficient
mice. We found that Jnk1/ Jnk2/ ES cells underwent self-renewal, but these cells proliferated more rapidly
than wild-type ES cells and exhibited major defects in lineage-specific differentiation. Together, these data
demonstrate that JNK is not required for proliferation or self-renewal of ES cells, but JNK plays a key role in
the differentiation of ES cells.
The c-Jun NH2-terminal kinase (JNK) is a member of the
mitogen-activated protein (MAP) kinase group of signaling
proteins. JNK is encoded by two ubiquitously expressed genes
(Jnk1 and Jnk2) and by a third gene (Jnk3) that is selectively
expressed in neurons (14). Gene disruption studies demon-
strate that mice without Jnk1 or Jnk2 are viable, but compound
deficiency of both Jnk1 and Jnk2 causes early embryonic le-
thality (14). Murine embryonic fibroblasts (MEFs) isolated
from Jnk1/ Jnk2/ mice exhibit a severe growth retardation
phenotype (54). The markedly reduced growth of Jnk1/
Jnk2/ MEFs is consistent with the finding that JNK is crit-
ically required for the regulation of AP1-dependent gene ex-
pression (56) that is implicated in cellular proliferation (26).
Thus, Jnk1/ Jnk2/ MEFs express low levels of AP1 pro-
teins (e.g., c-Jun and JunD) and exhibit marked defects in AP1
target gene expression (34, 56). This loss of AP1 function is
mediated, in part, by reduced phosphorylation of the activation
domain of Jun family proteins and ATF2 (56).
More recent studies using a conditional gene ablation strat-
egy have demonstrated that compound JNK deficiency causes
rapid senescence (12). This conclusion was confirmed by using
chemical genetic analysis with MEFs isolated from mice with a
germ line mutation that sensitizes JNK to inhibition by a pre-
designed small-molecule drug (12, 25). This form of senes-
cence was found to be p53 dependent (12) and resembles the
p53-dependent senescence of c-Jun/ MEFs (49). These data
indicate that JNK plays a critical role in cellular proliferation.
Indeed, it is possible that the p53-dependent senescence ob-
served in JNK-deficient cells may contribute to aging. This is
because altered p53 function is established to be an important
determinant of early aging (36, 55). Importantly, this role of
p53 in aging appears to be distinct from p53-mediated tumor
suppression and DNA damage responses (21, 39, 43).
One aspect of the aging process is a reduction in the regen-
erative capacity of stem cells (50). Indeed, it has been estab-
lished that altered p53 activity associated with aging causes
decreased stem cell function (8, 18, 42) and that disruption of
the p53 pathway can increase stem cell function (1). Since JNK
can influence p53-dependent senescence (12), these data indi-
cate that JNK may be important for stem cell proliferation and
self-renewal potential.
Embryonic stem (ES) cells proliferate and are capable of
both self-renewal and differentiation to multiple cell types.
Indeed, murine ES cells can differentiate to create all tissues
within a mouse. The profound growth retardation and rapid
p53-dependent senescence of Jnk1/ Jnk2/ MEFs (12) sug-
gests that JNK may play a critical role in the normal function
of ES cells, including self-renewal and differentiation potential.
The purpose of the present study was to test this hypothesis.
Our approach was to isolate ES cells from wild-type and JNK-
deficient mice. We demonstrate that JNK is not required for
self-renewal or the proliferation of ES cells. However, JNK is
required for ES cell differentiation.
MATERIALS AND METHODS
Mouse studies. Jnk1/ mice (16) and Jnk2/ mice (60) on a C57BL/6J
genetic background were described previously. C57BL/6J mice and C57BL/6J-
scid (B6.CB17-prkdcscid/SzJ) mice were obtained from the Jackson Laborato-
ries. These mice were housed in a facility that is accredited by the American
Association for Laboratory Animal Care and the studies were approved by the
Institutional Animal Care and Use Committee of the University of Massachu-
setts Medical School.
Genotype analysis. Jnk1 and Jnk2 genotypes were examined by PCR analysis
of genomic DNA (16, 60). Sex determination of ES cells was performed by PCR
amplification of genomic DNA to detect the presence of X and Y chromosomes
(46).
ES cell culture. Blastocysts (embryonic day 3.5 [E3.5]) were isolated (47) and
transferred to 24-well tissue culture dishes with a feeder cell layer of primary
mouse embryo fibroblasts (MEFs) inactivated with mitomycin C (Sigma) in
Dulbecco modified Eagle medium (DMEM; Invitrogen), 15% fetal bovine serum
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(Atlanta Biologicals), 2 mM glutamine, 1 mM sodium pyruvate, 100 M nones-
sential amino acids, 0.1 mM -mercaptoethanol (Invitrogen), and 1,000 U of
leukemia inhibitory factor (LIF) (Chemicon)/ml. Five days after plating, the
inner cell mass was treated with trypsin and harvested, and replated on feeder
cell layers in 24-well dishes. ES cell colonies were replated on feeder cell layers
every 2 to 3 days.
Retroviral transduction studies were performed by using the vector pMSCV-
Flag-JNK1-IRES-Puro (31). ES cells were plated on puromycin resistant RJ
feeder layers (provided by Stephen N. Jones, University of Massachusetts Med-
ical School) in ES cell growth medium (48 h) prior to infection. The medium was
replaced at 24 h postinfection with fresh medium supplemented with 2 g of
puromycin/ml. Positive ES cell clones were screened for expression of the JNK1
polypeptide by immunoblot analysis.
Embryoid bodies (EBs) were cultured by plating single cells in suspension
using DMEM supplemented with 10% fetal bovine serum (Invitrogen), 10%
newborn calf serum (Invitrogen), 1% horse serum (Invitrogen), and 2 mM
glutamine using uncoated petri dishes (8 days) and then 0.1% gelatin-coated
dishes (7 days). The number of cells was measured by transferring 100 EBs to 1
ml of phosphate-buffered saline (PBS) in one well of a 24-well culture plate.
These EBs were incubated with trypsin and dissociated to a single-cell suspen-
sion, and the number of cells was measured by using a hemacytometer.
Teratomas. ES cell-derived teratomas were prepared by subcutaneous injec-
tion of 4  106 ES cells into the flanks of C57BL/6J-scid mice. The mice were
euthanized at 3 weeks postinjection. The teratomas were removed, washed in
PBS, fixed (14 h) in 4% paraformaldehyde, and processed for histology.
Cardiomyocyte differentiation in vitro. ES cell-derived cardiomyocytes were
prepared in vitro (61). The ES cells were cultured using dishes coated with 0.1%
gelatin (3 days) in DMEM supplemented with 10% fetal bovine serum (Invitro-
gen), 10% newborn calf serum (Invitrogen), 1% horse serum (Invitrogen), 2 mM
glutamine, 0.1 mM -mercaptoethanol, 1,000 U of LIF/ml, and 0.15 g of
Noggin-Fc (R&D Systems)/ml. Single cells were cultured in the same medium
without LIF and -mercaptoethanol (1 day) and then in the same medium
without LIF (Chemicon), -mercaptoethanol, and Noggin-Fc (7 days) in suspen-
sion to form EBs using uncoated petri dishes. The EBs were transferred to
gelatin-coated tissue dishes and cultured for 16 days.
Immunohistochemistry. Paraformaldehyde-fixed tissue was processed, embed-
ded in paraffin, and 4-m sections were stained with hematoxylin and eosin
(H&E). Sections were also stained with antibodies to insulin (Dako), -fetopro-
tein (Meridian Life Science), troponin I (Santa Cruz), keratin 5/8 (Lab Vision),
desmin (Dako), Nestin (Chemicon), and the cytokeratin Endo-A (TROMA-1;
Developmental Studies Hybridoma Bank, University of Iowa) using indirect
immunoperoxidase detection (58). Alkaline phosphatase activity was measured
using cells fixed with 4% paraformaldehyde at room temperature (1 h) using the
Red Alkaline phosphatase substrate kit I (Vector). TUNEL (terminal de-
oxynucleotidyltransferase-mediated dUTP-biotin nick end labeling) assays were
performed by using an in situ cell death detection kit (Roche).
Immunofluorescence. Staining was performed using coverslips washed in PBS,
incubated in 90% methanol containing 5% acetic acid at 20°C (5 min), washed
with PBS, and then blocked by incubation with PBS supplemented with 1%
skimmed milk for 1 h at room temperature and incubated with antibodies to
SSEA-1 (Developmental Hybridoma Cell Bank, University of Iowa), Oct-4
(Chemicon), or FGF-4 (Santa Cruz, CA) in PBS containing 1% skimmed milk at
4°C (14 h). The cells were washed and then incubated with secondary antibodies
conjugated to Alexa Fluor 488 or Alexa Fluor 546 (Molecular Probes) at 37 °C
(1 h). Washed slides were mounted and examined by using a Leica SP2 laser-
scanning confocal fluorescence microscope.
Bromodeoxyuridine (BrdU) incorporation was examined by addition of 10 M
BrdU (Sigma) to the EB culture medium for 24 h. EB were fixed with 4% parafor-
maldehyde at 4°C (14 h) and embedded in OCT compound. Frozen sections (4 m)
were prepared, stained with a fluorescein isothiocyanate-conjugated antibody to
BrdU (BD-Pharmingen), and examined by fluorescence microscopy (59).
Electron microscopy. Cells were fixed with 1.25% glutaraldehyde (30 min) at
room temperature and with 2.5% glutaraldehyde in cacodylate buffer (14 h) at
4°C. The cells were then postfixed with 1% (wt/vol) osmium tetraoxide in PBS,
dehydrated, and embedded in Lx 112/Araldite 502 epoxy resin. Ultrathin sections
were mounted on copper support grids in serial order, contrasted with lead
citrate and uranyl acetate, and examined on a Philips CM 10 transmission
electron microscope (20).
Immunoblot analysis. Cell extracts were prepared by using Triton lysis buffer (20
mM Tris [pH 7.4], 1% Triton X-100, 10% glycerol, 137 mM NaCl, 2 mM EDTA, 25
mM -glycerophosphate, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl
fluoride, and 10 g of aprotinin and leupeptin/ml). Extracts (50 g) were examined
by immunoblot analysis. The blots were probed with antibodies to JNK (BD-Phar-
mingen), p38, ERK1, ERK2 (Santa Cruz), and -tubulin (Sigma). Immunocom-
plexes were detected by enhanced chemiluminescence (NEN).
RNA analysis. Total RNA was prepared by using an RNeasy lipid tissue
minikit (Qiagen) and was treated with DNase (Sigma). First-strand cDNA was
synthesized by using an iScript cDNA synthesis kit (Bio-Rad). PCR analysis was
performed using amplimers (Table 1).
Statistical analysis. Values are expressed as the mean  the standard devia-
tion. Comparisons among values for all groups were determined using a Student
t test.
RESULTS
Isolation of JNK-deficient ES cells. We prepared E3.5 blas-
tocysts from C57BL/6J mice and isolated ES cells in culture
TABLE 1. Amplimers used in this study
Gene
Amplimer pair sequences (5–3)
Amplimer 1 Amplimer 2
Anf GGGGGTAGGATTGACAGGAT CAGAGTGGGAGAGGCAAGAC
Apoa2 CACTGCTGGTAACCATCTG TCGAGGTTCATTAAACTGCT
BMHC CTACAGGCCTGGGCTTACCT TCTCCTTCTCAGACTTCCGC
Bmp4 GTTTCCTCTTCAACCTCAGC TATACGGTGGAAGCCCTGTT
Brachyury CTCACCAACAAGCTCAATGG ACAGCTATGAACTGGGTCTC
Emx2 AGCTTTTAAGGCTAGAGCAC CCTGAGTTTCCGTAAGACTG
Flk1 GGCGGTGGTGACAGTATCTT CTCGGTGATGTACACGATGC
Gata4 TGTCAATTGTGGGGCCATGTC GTGCCCCAGCCTTTTACTTTG
Hnf1 GAAAGCAACGGGAGATCCTCCGAC TAGGCATCCATGGCCAGCTTCTGC
Hnf3 TGGTCACTGGGGACAAGGGAA GCAACAACAGCAATAGAGAAC
Keratin17 GTAGTGCTCTTGGGAGCAACAG AGAACCAGTCTTCGGCATCCTT
MEF2c ACTGGGAAACCCCAATCTTC ATCAGACCGCCTGTGTTACC
Mlv2v AAAGAGGCTCCAGGTCCAAT CCTCTCTGCTTGTGTGGTCA
Nkx2.5 TGCAGAAGGCAGTGGAGCTGGACAAGCC TTGCACTTGTAGCGACGGTTCTGGAACCAG
Nodal TGGAGCGCATTTGGATGGAGAC TACTGCTTGGGGTAGATGATCC
Otx1 TTCACGCGCTCACAGCTGGA ACCAAACCTGGACTCTGGAC
Pax2 TGCCGAATACAAGCGACAGAAC TGGAAGACATCGGGATAGGAAG
Sox17 GCCAAAGACGAACGCAAGCGG TCATGCGCTTCACCTGCTTG
Transferrin ATTCTCAAAGTGGCACAGGAACAC GGGTTCTTTCCTTCGGTGTTATCC
Wnt1 TCTTCGGCAAGATCGTCAACCG AAGGTTCATGAGGAAGCGTAGG
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using a feeder layer of inactivated MEFs. Studies using mice
without or with targeted disruption of the Jnk1 and Jnk2 genes
led to the isolation of wild-type ES cell clones and also JNK-
deficient ES cell clones lacking expression of Jnk1 and/or Jnk2.
These clones were screened for the presence of X and Y
chromosomes, and 18 male (XY) ES cell clones were selected
for further study.
Representative ES cell clones were expanded in culture and
examined by immunoblot analysis. JNK isoforms (46 and 55
kDa) were detected in lysates prepared from wild-type ES cells
(Fig. 1A). Reduced expression of 46- and 55-kDa JNK iso-
forms was detected in lysates prepared from Jnk1/ and
Jnk2/ ES cells, respectively. In contrast, no JNK was de-
tected in lysates prepared from compound mutant Jnk1/
Jnk2/ ES cells (Fig. 1A). Control studies demonstrated that
these ES cells did not express different levels of other MAP
kinases (ERK1/2 and p38).
The wild-type and JNK-deficient ES cells grow as colonies
on feeder layers. No morphological differences between wild-
type and JNK-deficient ES cell colonies were detected, al-
though the compound mutant Jnk1/ Jnk2/ ES cells
formed larger colonies than did the other ES cells (Fig. 1B).
All of the ES cells we isolated expressed phenotypic markers
that characterize an undifferentiated state (Fig. 1C), including
alkaline phosphatase, SSEA-1, Oct-4, and FGF-4 (28). To-
gether, these data indicate that JNK deficiency does not pre-
vent the isolation of ES cells that express markers of the
undifferentiated state.
JNK is not essential for ES cell proliferation. Compound
JNK deficiency in MEFs causes severe growth retardation and
early senescence (12, 54). We therefore examined the growth
of wild-type and JNK-deficient ES cells grown as colonies. The
proliferation of wild-type and Jnk1/ ES cells was similar
(Fig. 1D). In contrast, Jnk2/ ES cells grew more rapidly than
wild-type ES cells and compound mutant Jnk1/ Jnk2/ ES
cells exhibited markedly increased proliferation compared to
wild-type ES cells (Fig. 1D). The high proliferation rate of
Jnk1/ Jnk2/ ES cells suggests that the normal function of
FIG. 1. Isolation of JNK-deficient ES cells. (A) Wild-type, Jnk1/, Jnk2/, and Jnk1/ Jnk2/ ES cells were examined by immunoblot
analysis with antibodies to JNK1/2, ERK1/2, p38 MAPK, and -tubulin. (B) Wild-type and JNK-deficient ES cells grown on a layer of feeder cells
(92 h) were examined by phase-contrast microscopy. Scale bar, 40 m. (C) ES cells were stained for alkaline phosphatase activity and with
antibodies to SSEA-1, Oct-4, and FGF-4. Scale bar, 40 m. (D) Wild-type and JNK-deficient ES cells (104 cells) were plated in six-well
gelatin-coated dishes. The number of cells on different days was measured. The data are shown as means  the standard deviations (SD) (n  3).
Statistically significant differences are indicated (*, P 	 0.05; **, P 	 0.01).
VOL. 30, 2010 ROLE OF JNK IN STEM CELLS 1331
 o
n
 June 1, 2016 by UNIV O
F M
ASS M
ED SCH
http://m
cb.asm
.org/
D
ow
nloaded from
 
JNK may be to limit ES cell proliferation and most likely
accounts for the observation that these cells form large colo-
nies on feeder cell layers (Fig. 1B). These data demonstrate
that JNK is not required for ES cell proliferation. This obser-
vation contrasts with the finding that JNK deficiency causes
rapid senescence in MEFs (12, 54).
JNK is required for the normal development of ES cell-
derived EBs. To examine the properties of wild-type and JNK-
deficient ES cells, we investigated the ability of these ES cells
to form EBs. Wild-type ES cells, Jnk1/ ES cells, and Jnk2/
ES cells formed EBs that increased in size (Fig. 2A) and cell
number (Fig. 2B) during culture in vitro. The Jnk1/ EBs, and
especially the Jnk2/ EBs, formed larger luminal spaces than
wild-type EBs (Fig. 2A). However, the proliferation of wild-
type, Jnk1/, or Jnk2/ cells in the EBs was similar (Fig. 2B).
This finding contrasts with the observation that undifferenti-
ated Jnk2/ ES cell colonies proliferated more rapidly than
wild-type or Jnk1/ ES cell colonies in culture (Fig. 1D).
The compound mutant Jnk1/ Jnk2/ ES cells also
formed EBs (Fig. 2A). These structures lacked the large lumi-
nal spaces found in Jnk1/ and Jnk2/ EBs (Fig. 2A) and the
number of cells within the compound mutant Jnk1/ Jnk2/
EBs did not increase during culture in vitro (Fig. 2B). Thus,
while JNK is not required for ES cell proliferation (Fig. 1D),
JNK is required for proliferation of cells that have initiated a
differentiation program (Fig. 2B). This stage-specific role for
JNK correlates with a change in the rapid cell cycles of ES cells
to the slower cell cycles of differentiated cells that include fully
formed gap (G1/G2) phases.
Previous studies have implicated JNK in both proliferation
and death (14). The effect of compound JNK deficiency to
prevent the accumulation of cells within EBs may therefore be
caused by changes in either cellular proliferation or death. To
test this hypothesis, we examined proliferation in EBs by in-
vestigating the incorporation of BrdU into DNA (Fig. 3) and
cell death by TUNEL assays (Fig. 4). These studies demon-
strated that the compound mutant Jnk1/ Jnk2/ EBs ex-
hibited decreased DNA synthesis and also decreased apopto-
sis. The failure of compound mutant Jnk1/ Jnk2/ EBs to
grow (Fig. 2B) is therefore accounted for by decreased prolif-
eration rather than increased cell death.
Role of JNK in the expression of endodermal lineage genes
in vitro. Development of the endoderm is one of the earliest
steps in embryonic development and genes associated with
endodermal differentiation (e.g., Apoa2, Hnf1, Hnf3, Sox17,
and Transferrin) are expressed during the formation of ES
cell-derived EBs. Transferrin and Hnf3 are essential for differ-
entiation of the visceral endoderm (7, 17) and show a similar
pattern of expression in EBs formed by wild-type and JNK-
deficient ES cells (Fig. 5A). Similarly, JNK deficiency did not
cause major changes in the expression of Apoa2, a gene that is
FIG. 2. Effect of JNK deficiency on the formation of EBs. (A) EBs
at days 3, 6, and 8 were examined by phase-contrast microscopy. Scale
bar, 250 m. (B) The number of cells per EB was measured. The data
are presented as the means the SD (n 100). Statistically significant
differences are indicated (*, P 	 0.05; **, P 	 0.001).
FIG. 3. Effect of JNK deficiency on proliferation. (A) Day 7 EBs
were pulse-labeled with BrdU and fixed. Frozen sections were stained
with DAPI (4,6-diamidino-2-phenylindole) and an antibody to BrdU
and then examined by immunofluorescence analysis. Scale bar, 150
m. (B) The mean fluorescence intensity of the BrdU immunofluo-
rescence was measured by using ImageJ software and is presented as
the means  the SD (n  100 EBs). Statistically significant differences
are indicated (*, P 	 0.05; **, P 	 0.01).
1332 XU AND DAVIS MOL. CELL. BIOL.
 o
n
 June 1, 2016 by UNIV O
F M
ASS M
ED SCH
http://m
cb.asm
.org/
D
ow
nloaded from
 
critically required for liver development (53). However, we
found JNK-dependent differences in the expression of Sox17
and Hnf1, genes that are required for differentiation of defin-
itive endoderm (27) and visceral endoderm (5), respectively.
Thus, Sox17 expression was downregulated in late-stage EBs
formed by JNK1/2-deficient ES cells compared to wild-type ES
cells (Fig. 5A). In contrast, the expression of Hnf1 was in-
creased at the early stages of EB formation by JNK1/2-defi-
cient ES cells compared to wild-type ES cells (Fig. 5A). To-
gether, these data indicate a nonessential role of JNK for
endodermal differentiation, but JNK may influence this devel-
opmental program.
Role of JNK in the expression of mesodermal lineage genes
in vitro. Members of the transforming growth factor- super-
family, including Bmp4 and Nodal, are implicated in the induc-
tion of mesoderm and gastrulation (4). Nodal was expressed at
similar levels in wild-type and JNK1/2-deficient EBs, but some
variations in Bmp4 expression were detected (Fig. 5B). These
data suggest that the initial development of mesoderm may be
JNK independent. Nevertheless, Brachyury, a gene that is crit-
ical for mesoderm development (22), was poorly expressed by
EBs formed by compound mutant Jnk1/ Jnk2/ ES cells
(Fig. 5B). This observation suggests that JNK may play an
important role in the development of mesodermal lineages.
To further examine the JNK dependence of mesodermal
lineage gene expression, we examined genes related to car-
diomyogenesis, including Flk1, Gata4, Nkx2.5, Mef2c, -Mhc,
Mlv2v, and Anf. These genes play important roles in the spec-
ification of cardiac progenitor cells and cardiac development
(6, 9, 19, 24, 29, 33, 35, 44, 45, 51). Expression of Gata4 and
Mef2c transcription factor mRNA was markedly reduced in
JNK1/2-deficient EBs at early stages of differentiation com-
pared to wild-type EBs (Fig. 5B). At late stages of differenti-
ation, very low levels of Flk1, Mef2c, -Mhc, Mlv2v, and Anf
gene expression were detected in EBs formed by compound
mutant Jnk1/ Jnk2/ ES cells (Fig. 5B). These data
strongly support the conclusion that the JNK pathway is im-
portant for mesodermal differentiation, including the develop-
ment of cardiac cells in vitro.
Role of JNK in the expression of ectodermal lineage genes in
vitro. We examined whether JNK deficiency affected the de-
velopment of ectoderm in ES cell-derived EBs. Keratin17 is a
marker for epidermal cells (41), and its expression was mod-
estly decreased in EBs formed by compound mutant Jnk1/
Jnk2/ ES cells compared to wild-type ES cells at late stages
of development (Fig. 5C). These data suggest that JNK is not
critically required for ectodermal differentiation.
Compound deficiency of Jnk1 and Jnk2 in embryos causes
early death associated with defects in neurogenesis (32). We
therefore examined the expression of genes related to early
neurogenesis in wild-type and JNK-deficient EBs. The expres-
sion of Emx2, a gene that is essential for forebrain develop-
ment (37), was decreased in JNK1/2-deficient EBs compared
to wild-type EBs (Fig. 2D). Expression of Otx1, a marker for
early neuroectodermal development that is expressed at the
1-3 somite stage in the anterior neuroectoderm of mouse em-
bryos (10), was increased in early stage JNK1/2-deficient EBs
(Fig. 5C). It has been established that Wnt1 and Pax2 regulate
mesencephalon and metencephalon development (38), and the
expression of these genes was markedly downregulated in EBs
formed by compound mutant Jnk1/ Jnk2/ ES cells com-
pared to wild-type ES cells (Fig. 5C). Together, these findings
support the conclusion that JNK contributes to ectoderm de-
velopment and indicate that JNK-deficient ES cells exhibit
abnormal neurogenesis in vitro.
Role of JNK in differentiation in vivo. In vitro analysis of ES
cells indicates that JNK can influence differentiation (Fig. 5).
Marker gene expression analysis demonstrated that JNK defi-
ciency caused large defects in the development of mesoderm
and more limited defects in ectodermal and endodermal de-
velopment in vitro (Fig. 5). Methods that can be used to study
differentiation in vivo include the analysis of mutant and mo-
saic mice. However, these approaches were not feasible for the
analysis of JNK function because Jnk1/ Jnk2/ mice die
during early embryonic development (32) and mosaic mice
prepared by injection of Jnk1/ Jnk2/ ES cells into wild-
type blastocysts exhibit low levels of chimerism (15). There-
fore, to test the role of JNK in differentiation in vivo, we
examined the formation of ES cell-derived teratomas, includ-
ing tissues formed by all three germ cell layers (Fig. 6 and 7).
Histological analysis of sections prepared from teratomas
demonstrated the presence of endodermal tissues (Fig. 6A).
Stratified columnar ciliated epithelium originates from the
endoderm (28) and a modest reduction in the amount of this
FIG. 4. Effect of JNK deficiency on apoptosis. (A) Day 7 EBs were
fixed and embedded in paraffin. Sections were stained with H&E and
examined by TUNEL assay. Scale bar, 250 m. A higher-magnification
image of a selected region (indicated with a box) of the TUNEL assay
is also shown. (B) The number of TUNEL-positive cells in sections of
EBs was measured and is presented as the mean  the SD (n  100
EBs). Statistically significant differences are indicated (*, P	 0.05; **,
P 	 0.01).
VOL. 30, 2010 ROLE OF JNK IN STEM CELLS 1333
 o
n
 June 1, 2016 by UNIV O
F M
ASS M
ED SCH
http://m
cb.asm
.org/
D
ow
nloaded from
 
tissue was detected in JNK-deficient teratomas (Fig. 6B). How-
ever, JNK deficiency was found to cause no difference in tis-
sues with serous gland-like cells or cuboidal ciliated epithelium
(Fig. 6B). Immunohistochemical staining of tissue sections for
the cytokeratin Endo-A (an endodermal marker) with the
TROMA1 antibody (30) did not reveal differences between
wild-type and JNK-deficient teratomas (data not shown). How-
ever, in contrast to wild-type teratomas, decreased numbers of
hepatocytelike cells (that stain with an antibody to -fetopro-
tein) and no insulin-positive pancreatic -like cells were de-
tected in compound mutant Jnk1/ Jnk2/ teratomas (Fig.
7A). These data indicate that JNK is not essential for endoder-
mal development, but JNK may influence differentiation of
some specific cell types derived from the endoderm.
Tissues with a mesodermal origin in wild-type and JNK-
deficient teratomas, including muscle, cartilage, and adipose
tissue, were examined. Major reductions in the amount of all
three tissues were detected in JNK-deficient teratomas com-
pared to wild-type teratomas (Fig. 6B). Immunohistochemical
staining of tissue sections using antibodies to cardiac muscle
FIG. 5. Effect of JNK deficiency on differentiation-associated gene expression in vitro. Semiquantitative reverse transcription-PCR (RT-PCR)
analysis was performed to detect the expression of mRNA associated with differentiation to endoderm (A), mesoderm (B), and ectoderm (C).
Total RNA from undifferentiated ES cells (un-diff) or various stages of EB development and differentiation between days 3 and 15 (EB-3d to
EB-15d) was examined. The amplimers used for this analysis are listed in Table 1. Gapdh gene expression was analyzed as an internal control. The
results are representative of three independent experiments.
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troponin I and striated muscle desmin indicated the presence
of both cardiomyocytelike and striated-muscle-like cells in
wild-type teratomas, but no cardiac muscle tropinin I and sig-
nificantly decreased striated muscle desmin were detected in
compound mutant Jnk1/ Jnk2/ teratomas (Fig. 7B).
These data indicate that mesoderm development is markedly
impaired by JNK deficiency in vivo.
We examined tissues with an ectodermal origin in wild-type
and JNK-deficient teratomas, including keratinized stratified
squamous epithelium, neuroepithelium, and skinlike struc-
FIG. 6. Effect of JNK deficiency of ES differentiation in vivo. (A) Subcutaneously injected ES cells form teratomas in congenic mice.
H&E-stained sections of teratomas formed by wild-type ES cells show the formation of endodermal (a to c), mesodermal (d to f), and ectodermal
(g to i) tissues. Scale bar, 60 m. (B) Comparison of teratomas derived from wild-type and JNK-deficient ES cells. Different tissues within sections
of teratomas were identified and the area within each section was determined by using ImageJ software. The relative expression of each tissue
within teratomas formed by ES cells with different genotypes is presented with a scale from “” (lowest) to “



” (highest). This scale is
defined in Table 2.
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tures. Studies of compound mutant Jnk1/ Jnk2/ teratomas
demonstrated reduced amounts of all three ectodermal tissues
compared to wild-type teratomas (Fig. 6B). Immunohisto-
chemical staining of tissue sections using an antibody to keratin
5/8, a marker for epidermal skin cells, demonstrated markedly
reduced expression in compound mutant Jnk1/ Jnk2/ ter-
atomas compared to wild-type teratomas (Fig. 7C). A small
decrease in Nestin expression (a marker of primitive neuroec-
toderm) was also detected in compound mutant Jnk1/
Jnk2/ teratomas compared to wild-type teratomas (Fig. 7C).
Together, these data indicate that JNK can play an important
role in ectoderm development in vivo.
JNK is not required for ES cell self-renewal. Studies of ES
cells in vitro and in vivo demonstrate that JNK deficiency
causes lineage-specific defects in differentiation (Fig. 5 to 7).
These defects in differentiation may result from either a role of
JNK in the differentiation program or because JNK-deficient
ES cells have lost their differentiation potential due to a failure
of self-renewal. To distinguish between these possibilities, we
performed complementation analysis using recombinant JNK
expressed in compound mutant Jnk1/ Jnk2/ ES cells. The
rationale for these studies was that if the ES cells exhibited a
failure of self-renewal, genetic complementation would not
lead to restoration of differentiation potential. In contrast, if
the JNK-deficient ES cells underwent self-renewal and JNK
was required for differentiation, genetic complementation
would restore differentiation potential.
We examined ES cells using a Noggin-induced differentia-
tion protocol that leads to the formation of cardiomyocytes
(61). Indeed, spontaneous beating of cell sheets was reproduc-
ibly detected within 6 days after attachment of wild-type,
Jnk1/, and Jnk2/ EBs in culture (Fig. 8A; see also Videos
S1 to S3 in the supplemental material). Within 16 days after
attachment, spontaneous beating of cells with a distinct muscle
morphology was observed (Fig. 8A; see also Videos S5 to S7 in
the supplemental material). Spontaneous beating is a property
of both cardiomyocytes and smooth muscle cells. To confirm
that these cultures contain cardiomyocytes (61), we examined
the differentiated cells by transmission electron microscopy.
Sarcomeric and Z-bands structures were detected consistent
with the presence of cardiomyocytes (Fig. 8B).
No spontaneously beating cell sheets or muscle were de-
tected in cultures of compound mutant Jnk1/ Jnk2/ cells
(Fig. 8A; see also Videos S4 and S8 in the supplemental ma-
terial). Indeed, gene expression analysis demonstrated that the
mesoderm marker Brachyury and the cardiomyocyte markers
Anf, Flk1, Mef2c, -Mhc, and Mlv2v expressed in wild-type
cultures were not expressed in cultures of compound mutant
Jnk1/ Jnk2/ cells (Fig. 8C). These data confirm that JNK
is essential for the formation of cardiomyocytes.
Complementation tests were performed using retroviral
transduction of epitope-tagged JNK11 in compound mutant
Jnk1/ Jnk2/ ES cells. Immunoblot analysis of cell lysates
demonstrated that the 46- and 55-kDa JNK isoforms present in
wild-type ES cells were absent in JNK-deficient ES cells (Fig.
8D). However, epitope-tagged JNK11 was detected in JNK-
deficient ES cells transduced with the JNK11 retroviral vector
(Fig. 8D). The expression of JNK11 in compound mutant
Jnk1/ Jnk2/ ES cells restored the wild-type ES cell phe-
notype, including gene expression (Anf, Brachyury, Flk1, Mef2c,
-Mhc, and Mlv2v) and the development of beating cardiomy-
ocytes in culture (Fig. 8E; see Video S9 in the supplemental
material). Furthermore, analysis of teratomas formed by the
complemented JNK-deficient ES cells demonstrated the res-
toration of cardiomyocyte development in vivo (Fig. 8F). To-
gether, these data confirm that JNK is required for the devel-
opment of cardiomyocytes and demonstrate that JNK is not
required for ES cell self-renewal.
DISCUSSION
Studies of primary MEFs demonstrate that Jnk1/ MEFs
proliferate more slowly than wild-type MEFs and that Jnk2/
MEFs proliferate more rapidly than wild-type MEFs (54). This
observation has been interpreted to indicate that JNK1 and
JNK2 may have opposite roles during proliferation (48). More
recent studies, using a chemical genetic approach, demonstrate
that these Jnk1/ and Jnk2/ phenotypes reflect adaptation
and gain-of-function of the remaining JNK isoform (25). Thus,
Jnk2/ MEFs have increased JNK1 protein kinase activity
compared to wild-type MEFs (25). These adaptive changes
may account for the effects of JNK1 or JNK2 deficiency on ES
cells. For example, Jnk1/ ES cells formed colonies more
slowly and Jnk2/ ES cells formed colonies more rapidly than
wild-type ES cells (Fig. 1D). Similarly, the increased luminal
space within JNK1- or JNK2-deficient EBs may reflect adap-
TABLE 2. Quantitation of teratoma cell typea
Tissue type
Mean % area




 


 

 
 
/– 
Cuboidal ciliated epithelium and goblet cells 15 10 5 1 0.1 0
Serous glandlike cells 0.4 0.3 0.2 0.1 0.01 0
Stratified columnar ciliated epithelium 4 3 2 1 0.1 0
Muscle 20 15 10 5 0.1 0
Cartilage 0.5 0.1 0.05 0.01 0.005 0
Fat 0.5 0.1 0.05 0.01 0.005 0
Keratinized stratified squamous epithelium 0.5 0.1 0.05 0.01 0.005 0
Neuroepithelium 30 20 10 1 0.1 0
Skinlike structures 1 0.5 0.1 0.05 0.01 0
a Sections of teratomas stained with H&E were examined to identify differentiated cell types (Fig. 6). The teratoma area for each differentiated cell type was
quantitated using ImageJ software (n  20). The mean percent area for each cell type was calculated and is represented on a scale from highest (“



”) to lowest
(“”) as discussed in the text.
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tation by the remaining JNK isoforms. Together, these consid-
erations illustrate the need for studies of compound mutants
that completely lack JNK expression.
It has been established that compound mutant Jnk1/
Jnk2/ MEFs proliferate slowly (54). Subsequent studies us-
ing conditional gene ablation and chemical genetic analysis
demonstrated that loss of JNK function resulted in rapid p53-
dependent senescence of MEFs (12). These data suggest that
JNK plays a critical role in cell proliferation. However, our
analysis of JNK-deficient ES cells indicates that the role of
JNK may be more complex that previously anticipated. We
show that compound mutant Jnk1/ Jnk2/ ES cells prolif-
erate more rapidly than wild-type ES cells when cultured as
undifferentiated colonies on feeder layers of inactivated MEF
(Fig. 1D). However, these JNK-deficient ES cells exhibit a
marked proliferation defect when cultured as EBs (Fig. 2 and
3). This analysis demonstrates that there is no obligate role of
JNK in the cell cycle, but JNK does influence cell cycle pro-
gression in a context-specific manner.
We speculate that these different roles of JNK in cell cycle
regulation reflect the interaction of JNK with the p53 pathway.
JNK deficiency does not cause growth inhibition in ES cells
FIG. 7. Defective differentiation of JNK-deficient ES cells in vivo. Sections of teratomas formed by wild-type and JNK-deficient ES cells were
examined by staining with H&E. (A) Hepatocytelike cells (upper panel) and -like cells (lower panel) of endodermal origin were detected by
staining with antibodies to -fetoprotein (AFP) and insulin. Scale bars: upper, 250 m; lower, 125 m. (B) Cardiomyocytelike cells (upper panel)
and striated-muscle-like cells (lower panel) of mesodermal origin were detected with antibodies to troponin I and desmin. Scale bars, 250 m.
(C) Keratinocytelike cells (upper panel) and primitive neuroepitheliumlike cells (lower panel) of ectodermal origin were detected with antibodies
to keratin5/8 and nestin. Scale bars, 250 m.
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that exhibit rapid cell cycles that lack fully formed gap (G1/G2)
phases (57). Moreover, it is established that the p53 pathway
fails to mediate growth arrest in ES cells (2, 23), in part,
because of cytoplasmic retention of p53 (52). In contrast, ES
cells grown in EBs initiate a differentiation program that
changes the cell cycle to include fully formed gap (G1/G2)
phases (57). Similarly, the cell cycle of MEFs includes fully
formed gap phases (57). The effect of JNK deficiency to cause
p53-dependent growth inhibition therefore correlates with the
presence of gap (G1/G2) phases in the cell cycle.
JNK and developmental apoptosis. Cavity formation in EBs
is a critical process that is required for differentiation and
maturation (3, 40). The mechanism of cavity formation is me-
diated by programmed cell death of the inner ectodermal cells
and survival of the outer ectodermal cells that form a columnar
epithelium mediated by contact with the basement membrane
FIG. 8. JNK is not required for ES cell self-renewal. (A) ES cell-derived cardiomyocytes after 6 or 16 days of differentiation were examined
by phase-contrast microscopy. Scale bar, 20 m. The images represent single frames of movies (see Videos S1 to S8 in the supplemental material).
(B) Cardiomyocytes derived from wild-type ES cells were examined by transmission electron microscopy. Sarcomeric and Z-band structures were
detected. Scale bar, 1 m. (C) Complementation analysis demonstrates that the expression of Flag-JNK1 in in Jnk1/ Jnk2/ ES cells restored
the expressed of mesodermal differentiation markers in EBs at 15 days. Total RNA was isolated and mRNA expression was examined by
semiquantitative RT-PCR analysis. (D) Flag-JNK1 was expressed in Jnk1/ Jnk2/ ES cells by retroviral transduction. The amount of JNK and
-tubulin in ES cell lysates was examined by immunoblot analysis. (E) Beating ES cell-derived cardiomyocytes in cultures of Jnk1/ Jnk2/ ES
cells that express Flag-JNK1 were detected by phase-contrast microscopy. Scale bar, 20 m. The image represents a single frame of a movie (see
Video S9 in the supplemental material). (F) Sections of teratomas derived from Jnk1/ Jnk2/ ES cells that express Flag-JNK1 demonstrate the
presence of cardiomyocytelike structures stained with H&E (left) and an antibody to troponin I (right). Scale bar, 250 m.
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(11). This mechanism of dual signaling to selectively target
ectodermal cells for survival and death is an essential step in
development. Previous studies have established that com-
pound mutant embryos lacking Jnk1 and Jnk2 exhibited severe
dysregulation of cell survival and apoptosis (32). It was there-
fore possible that JNK may contribute to cavitation. Indeed,
Jnk1/ Jnk2/ ES cells formed EBs without cavitation (Fig.
2). This loss of cavitation was associated with reduced apop-
tosis and also with reduced proliferation (Fig. 3 and 4). These
data demonstrate that JNK is required for a very early mor-
phogenetic process that involves developmentally regulated
apoptosis. It is likely that the loss of cavitation has profound
consequences for differentiation. This is consistent with the
finding that Jnk1/ Jnk2/ ES cells exhibit a reduced capac-
ity to differentiate (Fig. 5 to 8).
Stem cell self-renewal and differentiation. The observation
that Jnk1/ Jnk2/ ES cells exhibit a profound defect in
differentiation (Fig. 5 to 8) could reflect either a requirement
of JNK for the maintenance of stem cell totipotency or a
requirement of JNK for differentiation. We used genetic
complementation assays to distinguish between these possibil-
ities. We found that the ectopic expression of JNK in Jnk1/
Jnk2/ ES cells was fully capable of restoring the differenti-
ation of these cells to a mesodermal lineage (Fig. 8). This
finding demonstrates that the self-renewal potential of ES cells
does not require JNK. However, JNK is required for specific
differentiation programs. This conclusion is consistent with the
finding that radiation chimeras prepared by transplantation of
Jnk1/ Jnk2/ bone marrow into lethally irradiated recipient
mice results in the reconstitution of these animals by Jnk1/
Jnk2/ hematopoietic stem cells (13).
Conclusions. We report that JNK is not required for stem
cell self-renewal. However, JNK does play a major role in the
suppression of senescence, proliferation, apoptosis, and differ-
entiation of ES cells that have committed to a specific cell
lineage.
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